Elsevier

Journal of Clinical Densitometry

Volume 20, Issue 2, April–June 2017, Pages 134-152
Journal of Clinical Densitometry

Review Article
Proceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases

https://doi.org/10.1016/j.jocd.2017.01.001Get rights and content
Under a Creative Commons license
open access

Abstract

The Santa Fe Bone Symposium is an annual meeting of healthcare professionals and clinical researchers that details the clinical relevance of advances in knowledge of skeletal diseases. The 17th Santa Fe Bone Symposium was held in Santa Fe, New Mexico, USA, on August 5–6, 2016. The program included plenary lectures, oral presentations by endocrinology fellows, meet-the-professor sessions, and panel discussions, all aimed to provide ample opportunity for interactive discussions among all participants. Symposium topics included recent developments in the translation of basic bone science to patient care, new clinical practice guidelines for postmenopausal osteoporosis, management of patients with disorders of phosphate metabolism, new and emerging treatments for rare bone diseases, strategies to enhance fracture healing, and an update on Bone Health Extension for Community Healthcare Outcomes, using a teleconferencing platform to elevate the level of knowledge of healthcare professionals in underserved communities to deliver best practice care for skeletal diseases. The highlights and important clinical messages of the 2016 Santa Fe Bone Symposium are provided herein by each of the faculty presenters.

Key Words

DXA
ECHO
osteoporosis
phosphorus

Cited by (0)

Conflicts of interest: E. Michael Lewiecki, MD, Research Grant: Amgen, Lilly, Merck; Consultant: Amgen, Lilly, Merck, Radius, Alexion, Shire, AbbVie. John P. Bilezikian, MD, Research Grant: Shire; Consultant: Amgen, Shire, Radius. Susan V. Bukata, MD, Consultant: Merck, Amgen, Lilly. Pauline Camacho, MD, Research Grant: Amgen, Lilly; Consultant: Amgen. Bart L. Clarke, MD, Research Grant: Shire. Michael R. McClung, MD, Consultant: Amgen, Merck, Radius. Paul D. Miller, MD, Research Grants: Amgen, Alexion, Merck, Merck Serrano, Boehringer Ingelheim, Novartis, Novo Nordisk, Immunodiagnostics, Roche Diagnostics, Takeda, National Bone Health Alliance; Consultant: Amgen, Lilly, Merck, Alexion, AgNovos, Radius, Roche; Speaker: Alexion, Amgen, Radius. John Shepherd, PhD, Nothing to disclose.